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Background: The influenza A virus NS1 protein is a virulence factor and an antagonist of host cell innate immune
responses. During virus infection NS1 protein has several functions both in the nucleus and in the cytoplasm and
its intracellular localization is regulated by one or two nuclear localization signals (NLS) and a nuclear export
signal (NES).
Methods: In order to investigate the role of NS1 NES in intracellular localization, virus life cycle and host interferon
responses, we generated recombinant A/Udorn/72 viruses harboring point mutations in the NES sequence.
Results: NS1 NES was found to be inactivated by several of the mutations resulting in nuclear retention of NS1 at
late stages of infection confirming that this sequence is a bona fide functional NES. Some of the mutant viruses
showed reduced growth properties in cell culture, inability to antagonize host cell interferon production and
increased p-IRF3 levels, but no clear correlation between these phenotypes and NS1 localization could be made.
Impaired activation of Akt phosphorylation by the replication-deficient viruses indicates possible disruption of
NS1-p85β interaction by mutations in the NES region.
Conclusion: We conclude that mutations within the NS1 NES result in impairment of several NS1 functions which
extends further from the NES site being only involved in regulating the nuclear-cytoplasmic trafficking of NS1.
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Influenza A virus has a segmented genome consisting
of eight single stranded negative-sense RNA molecules,
which encode for 14 different proteins. Some of these pro-
teins, such as the HA, PB1-F2 and NS1 proteins contri-
bute to the virulence of the virus [1]. The 26 kDa NS1
protein is a remarkably multifunctional protein. Through
protein-RNA and protein-protein interactions NS1 is cap-
able of preventing the production of interferons in virus-
infected host cells and inhibiting the antiviral actions of
interferon-induced proteins (reviewed by [2]). The inhib-
ition of interferon production is facilitated by the ability of
NS1 to inhibit the functions of a cytoplasmic RNA sensor
RIG-I through interaction with TRIM25 [3]. In addition,* Correspondence: janne.tynell@thl.fi
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hibit the nuclear proteins CPSF30 and PABII, which func-
tion in the 3′-end processing of cellular pre-mRNAs [4,5].
The inhibition of interferon-induced dsRNA-activated
proteins PKR and 2′-5′-oligoadenylate synthetase (OAS)
is mediated through direct binding of NS1 to PKR [6] and
through sequestering of dsRNA from OAS by the N-
terminal RNA-binding domain of NS1 [7]. Moreover, NS1
has been suggested to inhibit the host RNAi pathway [8]
and it is also involved in many regulatory functions such
as controlling the host cell splicing machinery [9,10], en-
hancing the translation of viral mRNA [11] and activating
the PI3K pathway [12].
Since NS1 has many functions both in the nucleus and in
the cytoplasm, it is clear that the intracellular localization
of NS1 must be controlled accordingly. Structural and
functional studies of the NS1 protein have recognized an
N-terminal nuclear localization signal (NLS1) involvingtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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port signal (NES) within amino acids 138–147 [14] and a
C-terminal nuclear/nucleolar localization signal (NLS2/
NoLS) comprising of the basic amino acids at positions
219, 220, 224 and 229 and including also amino acids 231
and 232 in NS1 proteins which have a C-terminal exten-
sion [15,16]. Localization studies have shown that NS1 lo-
calizes predominantly in the nucleus, but it is translocated
into the cytoplasm at late stages of infection possibly due
to the unmasking of NES or, in the event of a competitive
relationship between NLS and NES, perhaps because of
masking of the NLS signals.
All NS1 proteins have a putative well-conserved NES,
which is characterized as a classical hydrophobic leucine-
rich export signal consisting of the consensus sequence Φ-
XX(X)-Φ-XX(X)-Φ-X-Φ, where Φ represents L, I, F, V or
M and X represents any amino acid. Leucine-rich NESs
are typically recognised by the chromosome region main-
tenance 1 (CRM1) exportin molecule, which directly binds
to NES and mediates the transport of NES-containing mol-
ecules through the nuclear pore complex in a NES-CRM1-
Ran-GTP ternary complex (reviewed by [17]). Recently it
was suggested that some leucine-rich NES-containing pro-
teins may be translocated into the cytoplasm independ-
ently of CRM1 [18,19]. Accordingly, a FRET analysis of
transiently expressed NS1 protein failed to demonstrate a
direct interaction of NS1 with CRM1 [20]. However, since
the NES of ectopically expressed NS1 has been reported to
remain inactive in uninfected cells [14], this observation
has to be verified in the context of live virus infection.Figure 1 The nuclear export signal of A/Udorn/72 NS1. A, schematic re
(aa 35–41), NES (aa 138–146) and NLS2/NoLS (aa 219–232) indicated. B, seq
into the NES sequence to create recombinant mutant viruses. C, molecular
A/Udorn/72 NS1 effector domain based on the crystal structure by Xia et a
indicated in red. The figure was created using RasMol 2.7.3. program (http:/In the present study we generated recombinant influ-
enza A viruses with mutations in the putative NES of
NS1 protein. We show that mutations in the NES of
NS1 molecule results in nuclear retention of the NS1
protein at late stages of infection. In addition, we ob-
tained mutant viruses that had a reduced capacity to
replicate in cell culture and showed enhanced activation
of IRF3 and production of antiviral interferons (IFN).
Lack of efficient Akt phosphorylation by the growth-
deficient viruses suggests impairment of the NS1-p85β
interaction by mutations within the NES.
Results
The NS1 nuclear export signal is well-conserved within
the majority of influenza A virus strains
A schematic presentation of the NS1 protein structure
(A/Udorn/72 virus NS1) is shown in Figure 1. The NS1
NES is located in the middle of the effector domain and
comprises of a phenylalanine and three leucines each
separated by one or two amino acids (Figure 1A). Within
the dimeric structure of the effector domain the NES se-
quences are partially buried in the molecule (Figure 1C).
In order to determine the conservation rate of the NS1
NES we compared more than 25,000 influenza A NS1
amino acid sequences available (as of September 2013)
in the Influenza Research Database [21] using the se-
quence variation analysis tool accessible on the website
http://www.fludb.org (Table 1). The NES consensus se-
quence (F138, L141, L144 and L146) appears to be highly
conserved within all influenza A strains regardless of hostpresentation of A/Udorn/72 NS1 with the localization signals NLS1
uence of A/Udorn/72 NS1 NES region and the mutations introduced
surface representation of the position of NES within the dimeric
l. [22] (PDB ID 3EE8). Amino acids of the NES consensus sequence are
/rasmol.org/).
Table 1 Amino acid conservation of the NS1 NES region
Position Consensus Prevalence Percentage
138 Phe 24424/25183 96,99%
139 Asp 15412/25183 61,20%
140 Arg 22525/25183 89,44%
141 Leu 24763/25183 98,33%
142 Glu 24916/25183 98,94%
143 Thr 22149/25183 87,95%
144 Leu 21822/25183 86,65%
145 Ile 16910/25183 67,15%
146 Leu 22655/25183 89,96%
147 Leu 25105/25183 99,69%
148 Arg 25099/25183 99,67%
149 Ala 25134/25183 99,81%
150 Phe 25092/25183 99,64%
A consensus sequence for the region was derived by running 25183 NS1
sequences through the Analyze Sequence Variation (SNP) tool on the
Influenza Research Database –website (http://www.fludb.org). Prevalence of
each amino acid is indicated as a total number and percentage within all the
analyzed sequences.
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export signal (aa 147–150) is also very highly conserved.Mutations in the putative nuclear export signal lead to
nuclear retention of NS1 at late stages of infection
In order to determine the key amino acids regulating the
nuclear export of NS1 protein we created different A/
Udorn/72 mutant viruses with one or two point mutations
introduced into the putative NES sequence (Figure 1B). In
addition, we also generated NS1 A149V mutant virus, since
this mutation has been linked to an attenuated phenotype
in an avian influenza A virus [23]. The impact of the puta-
tive NES mutations on NS1 intracellular localization at dif-
ferent stages of infection was studied in A549 cells by
immunofluorescence assay (Figure 2) followed by quantita-
tive analysis of the intracellular localization of wild type
and mutant NS1 proteins (Figure 3). At early stages of in-
fection there were no marked differences between the
localization patterns of the mutated proteins and the wild-
type NS1 protein, since in all cases the protein was found
both in the nucleus and the cytoplasm. At later stages of
infection (16 h and later), however, most of the mutant
NS1 proteins (L141A), (A149V), (F138A, L141A) and
(L144A, L146A) accumulated in the nucleus leaving the
cytoplasm almost or completely devoid of NS1 protein,
while a significant proportion of the wild-type NS1 pro-
tein localized into the cytoplasm in addition to the nu-
cleus. The NS1 L146A mutant protein behaved very
similarly to that of the wt NS1 protein and thus this
point mutation appears to be insufficient to fully inacti-
vate the NES (Figures 2 and 3).Inactivation of the NS1 NES has limited impact on
replication of the virus
Next we analyzed the effect of NES mutations on the viral
growth properties of different recombinant viruses. We in-
fected MDCK cells with the wt and NES-mutant viruses
at very low MOI values (0.001) and measured the virus ti-
ters from samples taken at 12 h intervals. The growth
curves derived from the results showed no major differ-
ences in mutant virus titers as compared to the wild type
virus, with the exception of the (A149V) and (L144A,
L146A) NS1 mutant viruses (Figure 4). The growth of
(L144A, L146A) NS1 mutant virus was strongly inhibited,
presenting approximately 1000-fold lower titers through-
out the infection than the wt virus. Also the growth kinet-
ics of (L144A, L146A) NS1 mutant virus was delayed with
peak titer achieved only at 36 h after infection as com-
pared to 24 h with all the other viruses. The (A149V) NS1
mutant virus displayed equal titers with wt virus at the
12 h time point, but afterwards only grew to 10–100 fold
lower titers than the wt virus. The observed reduction in
virus production is not directly linked with the inactiva-
tion of the NES, since (L141A) and (F138A, L141A) NS1
mutant viruses show clear inactivation of NES and accu-
mulation of NS1 protein in the nucleus (Figure 2) and yet
they replicated very well in MDCK cells. To investigate
whether the observed growth defects correlated with any
deficiencies in viral protein expression, we infected A549
cells at MOI 1 and analyzed the expression of NP, NS1,
M1 and NEP in cell lysate samples collected at 2 h, 4 h,
6 h, 8 h, 12 h and 24 h post-infection by Western blotting
(Figure 5). All viruses displayed largely similar viral protein
expression kinetics throughout the infection (Figure 5),
but there was a clear reduction in the levels of NS1 and
NEP production by the (L144A, L146A) mutant virus and
some less pronounced variation among the other viruses.
NEP mediates viral ribonucleoprotein (vRNP) export [24],
so we checked for any differences in vRNP localization by
visualizing NP localization by immunofluorescence in
infected A549 cells (Additional file 1: Figure S1 and
Additional file 2: Figure S2), but found no differences
between the viruses.
The NS1 mutations A149V and L144A, L146A lead to
increased interferon production
In order to analyse whether the reduced replication of
(A149V) and (L144A, L146A) mutant viruses is the result
of an impaired ability of NS1 protein to block host cell
interferon production, we infected A549 cells with the 5
mutant viruses and the wild-type virus at different MOI
values and measured the production of IFN-β and IFN-λ1
into the supernatants at 20 h post infection (Figure 6A
and B). Recombinant wild type A/Udorn/72 virus and
NS1 (L141A), (L146A) and (F138A, L141A) mutant vi-
ruses were very weak in their ability to induce IFN-β and
Figure 2 Nuclear-cytoplasmic localization of wild-type and mutant NS1 proteins in A549 cells during infection. A549 cells were infected
with the recombinant A/Udorn/72 viruses at MOI 1 for times indicated in the figure followed by fixation with 3% paraformaldehyde. Cells were
permeabilized, stained with guinea pig anti-NS1 and secondary antibodies and processed for detection by immunofluorescence microscopy. The
pictures were taken with Leica TCS NT confocal microscope. Data shown is representative of three independent experiments.
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However, NS1 (A149V) and especially NS1 (L144A,
L146A) mutant viruses readily induced relatively high
IFN levels in response to the infection (Figure 6A and B).
Consistent with the ELISA data, Western blot analysis
of cell lysates from virus-infected cells showed high
levels of phosphorylated form of IRF3 (p-IRF3) and en-
hanced expression of MxA protein for the NS1 (A149V)
and (L144A, L146A) viruses (Figure 6C). Interestingly,
NS1 (L141A), (L146A) and (F138A, L141A) mutant vi-
ruses were also able to induce stronger IRF3 phosphor-
ylation than the wt virus and detectable levels of MxA
(Figure 6C), even though only low levels of IFN were
produced by these viruses (Figure 6A and B). Since the
phosphaditylinositol-3-kinase (PI3K) pathway is also acti-
vated and regulated by NS1 protein during influenza virusinfection [12], we analyzed whether NES mutations
would also have an effect on Akt phosphorylation.
Interestingly, the amount of p-Akt within the infected
cells was clearly reduced in the NS1 (A149V) and
(L144A, L146A) mutant virus infected cells, suggesting
an impairment of the PI3K activating functions of NS1.
A notable feature was also the clear reduction in NS1
levels for the mutant virus (L144A, L146A) (Figure 6C),
indicating a possible impairment of protein stability
caused by the mutations. For better comparison of NS1
expression levels, a new Western blot analysis with fur-
ther diluted samples was performed and band intensities
were analyzed with ImageJ (http://imagej.nih.gov/ij/) soft-
ware, revealing an almost 50% reduction in NS1 (L144A,
L146A) expression levels as compared to wild type virus
(Additional file 3: Figure S3).
Figure 3 Localization patterns of wild-type and mutant NS1 proteins in A549 cells. A549 cells were infected with different recombinant
A/Udorn/72 viruses for times indicated after which they were fixed, permeabilized and processed for detection by immunofluorescence. For each
time point five random frames under the fluorescence microscope (≈100 cells) were inspected and the intracellular localization of NS1 protein
was estimated and presented in a quantitative manner. Data shown is from the same samples as the immunofluorescence pictures in Figure 2.
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mutant viruses is not due to inability of NS1 to bind CPSF
The NES-region of NS1 has also been proposed to play a
role in CPSF binding [25]. In order to study whether the
observed increase in interferon production was due to an
inability of the NS1 protein to bind CPSF, we created the
mutations (A149V), (L144A, L146A) and (F138A, L141A)
into GST-NS1 expression constructs and compared their
ability to bind CPSF30 to that of wild-type NS1 in a GST
pull-down assay combined with autoradiography (Figure 7).
As shown in Figure 7, all the mutant GST-NS1 proteinsFigure 4 Growth kinetics of the recombinant viruses in MDCK
cells. MDCK cells on 6-well plates were infected at MOI values of
0.001 for 1 h after which virus inoculum was removed and fresh
growth medium was added. The cells were incubated at 37°C
humidified 5% CO2 conditions and supernatant samples were taken
at 12 h intervals and analyzed by endpoint dilution on MDCK cells.
Mean values from three independent experiments are shown for
each sample.bind CPSF30 equally well and thus we can conclude that
the NES mutations are unlikely to have an effect on NS1
CPSF-binding.
NS1 protein export during influenza A infection is likely
not mediated by CRM1
The nuclear export of NES-containing proteins is often
regulated by the nuclear export protein, CRM1. An anti-
fungal antibiotic, leptomycin B (LMB) is able to directly
bind to CRM1 [26] and thus block NES-dependent nu-
clear export of proteins. In order to analyze whether
the nuclear export of influenza A virus NS1 protein is
dependent on CRM1 we treated wt virus-infected cells
with LMB and analyzed the intracellular localization of
NS1 protein by immunofluorescence at 20 h post infec-
tion (Figure 8). As a positive control we included the
analysis of viral NP, since its export from the nucleus
has previously been shown to be dependent on CRM1
[27]. For a quantitative assessment 6–8 random frames
(≈100 cells) were inspected under the microscope and
NS1 and NP localization was estimated and presented in
a graph (Figure 8). NP was clearly found to be retained
in the nucleus in LMB-treated cells confirming the
successful inhibition of CRM1 functions. NS1, however,
showed little difference in localization between LMB-
and mock-treated cells with most cells displaying NS1
both in the nucleus and the cytoplasm. This suggests
that LMB treatment was inefficient in inhibiting the nu-
clear export of NS1 indicating that the export of this
protein is likely independent or only partially dependent
on CRM1.
Figure 5 Expression kinetics of viral proteins during infection. A549 cells were infected at MOI 1 with A/Udorn/72 wild type and mutant
viruses and cell lysates were collected at the indicated time points. The amounts of NS1, NP, NEP, M1 and actin in the lysates were visualized by
immunoblotting (10 μg total protein/lane). Data shown is representative of three independent experiments.
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In the present study we have carried out a detailed func-
tional analysis of influenza A virus NS1 protein NES
element, which is extremely well-conserved among all
presently known influenza A virus strains and represents
a typical consensus NES-type sequence. We show that
mutations in the NES element, with the exception of
mutation L146A, lead to nuclear retention of NS1 at late
stages of infection, indicating an inactivation of the NES.
NES-inactivating NS1 mutations (L144A, L146A) and
(A149V) were associated with severe inhibition of viral
growth properties and inability of the mutant virus to in-
hibit host cell interferon production.
Regulation of the mechanisms of NS1 NES function
during infection is unknown, although the amino acid re-
gion immediately after the consensus-like NES element
has been suggested to play a regulatory role in the nuclear
export of NS1 [14]. This may take place by masking of the
export signal at early times of infection and by allowing
the exposure of the NES element at later time points by
some activating event. The fact that some activation eventis required for triggering the nuclear export of NS1 pro-
tein is well supported by the structure of NS1 (Figure 1C).
Leucine residues in the NES element are of hydrophobic
nature and for them to become in contact with export
molecules relatively drastic conformation changes are
required. Inactivation of the NES by the A149V muta-
tion, which renders the protein strongly nuclear at late
time points (Figure 2), also supports the view that some
masking sequence is regulating the accessibility of the
consensus leucine residues to the export machinery.
Interestingly, the A149V NS1 mutation has been linked
to pathogenesis in chickens when it was discovered in
the context of a natural H5N1 virus strain that was cir-
culating in poultry [23].
The observed reduction in viral replication of the NS1
mutant viruses (A149V) and (L144A, L146A) (Figure 4)
was likely due to impaired IFN antagonist functions of
mutant NS1 proteins. These viruses readily induced IFN
production into cell culture supernatant, as evidenced by
the ELISA assays (Figure 6A and B), and also showed in-
duction of IFN induced MxA protein (Figure 6C). Upon
Figure 6 The effect of NS1 NES mutations on recombinant virus-induced interferon production and IRF3 and Akt phosphorylation.
A549 cells on 6-well plates were infected at three different MOI values for 20 h after which the supernatants and cell lysates were collected.
A and B, quantitation of IFN-β and IFN-λ1 from the supernatants by ELISA. All samples were analyzed in duplicates and the data shown is
representative of three independent experiments. Statistical significance is calculated against the wt samples (*p < 0.05, **p < 0.01).
C, Virus-infected cells (MOI 1) were collected at 20 h postinfection, lysed and processed for SDS-PAGE and Western blotting in three different
dilutions (10, 5 or 1 μg of total protein/well). Filters were stained with antibodies against p-IRF3, p-Akt, MxA, actin and NS1 proteins and relative
protein expression is shown in the figure. Data shown is representative of three independent experiments.
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correlate with very high virus activated p-IRF3 levels as
compared to wild-type virus, suggesting the inability of
these mutant NS1 proteins to inhibit the RIG-I pathway.
Strong expression of p-IRF3 was also observed with the
other nuclearly localized NS1 mutant viruses (L141A) and
(F138A, L141A), which might be explained by the nuclear
NS1 being unable to inhibit cytoplasmic RIG-I. However,
this correlation remains unclear since strong phosphoryl-
ation of IRF-3 was also associated with the L146A NS1
mutant virus, which shows a similar NS1 localizationFigure 7 The nuclear export -deficient mutants of the full length influ
protein in a GST pull down experiment. [35S]-labeled and in vitro-transla
immobilized GST, GST-NS1 A/Udorn/72 wt, GST-NS1 F138A, L141A, GST-NS1
proteins were dissolved in Laemmli sample buffer, separated on 12% SDS-P
[35S]-labeled protein that was used in binding experiment. M indicates the Se
on 12% SDS-PAGE and stained with Coomassie Blue to visualize the amount opattern as the wild type virus. Lack of potent IFN produc-
tion despite strong p-IRF3 activation by the (L141A) and
(F138A, L141A) NS1 mutant viruses indicates, that in the
case of at least some nuclearly retented mutant NS1 pro-
teins, the nuclear functions of NS1 in the absence of cyto-
plasmic NS1 are sufficient to inhibit IFN production.
Detectable levels of MxA were observed with all the mu-
tant viruses despite low IFN production by some of them,
which is probably due to even low IFN production being
enough to cause some MxA production. It was also of
interest that Western blot analysis revealed diminishedenza A/Udorn/72 NS1 protein bind in vitro-translated CPFS30
ted CPFS30 was allowed to bind to E. coli-expressed and Sepharose-
L144A, L146A and GST-NS1 A149V at +4°C for 1 h. Sepharose-bound
AGE and autoradiographed. Input, lane C, was 1:20 of the amount of
pharose matrix-bound proteins. The same samples were also separated
f Sepharose-immobilized GST and GST-NS1 fusion proteins.
Figure 8 Effect of leptomycin B treatment on NS1 intracellular localization. A549 cells were infected with wild-type A/Udorn/72 virus and
incubated with or without 2 ng/ml LMB added at 3 h postinfection. 20 h postinfection the cells were fixed and the intracellular localization of
NS1 protein and NP were visualized by immunofluorescence and estimated in a quantitative manner by observing 6–8 random frames under the
microscope. The pictures were taken by Leica TCS NT confocal microscope. Data shown is representative of three independent experiments.
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tants adding further evidence that multiple NS1 func-
tions may be affected by the mutations. This suggests a
more extensive structural or functional importance of
the NES region. In a study investigating the structural
conservation of the whole NS1 protein, Leu144 and
Ala149 were found to be very well-conserved and were
suggested to play a role in stabilizing the protein struc-
ture [28]. The observed reduction of almost 50% in the
levels of NS1 (L144A, L146A) compared to wild type
NS1 (Additional file 3: Figure S3) supports the idea of a
stabilizing role for the NES region, but this is unlikely
to have an impact on viral growth properties or IFN
production since very low levels of NS1 have been
shown to be sufficient for normal replication and IFN
antagonism [29]. The NES region has also been suggested
to be involved in CPSF binding [25], but an X-ray crystal
structure published on the NS1-CPSF complex somewhat
later does not support this view [30]. Nevertheless, we an-
alyzed whether any of our inserted mutations affected
CPSF-binding of NS1 on GST pull-down assay and found
that binding to CPSF30 was similar to that of wild-type
NS1 (Figure 7).
Besides being involved in regulating splicing and nuclear
export of mRNA [10], NS1 has also been shown to influ-
ence temporal regulation of viral RNA and protein synthe-
sis [31]. Thus we explored whether the introduced NES
mutations might have an effect on viral protein expression
kinetics (Figure 5). In addition to NS1, we included an
abundant early gene product (NP), a late gene product
(M1) and a spliced gene product (NEP). At a glance, ex-
pression kinetics of all the analyzed proteins appear simi-
lar between the wild type and mutant viruses (Figure 5),
but there are some differences in expression levels at cer-
tain time points. The growth deficient viruses (A149V)and especially (L144A, L146A) produce somewhat lower
levels of NS1 and NEP, whereas the (L141A) and (L146A)
viruses are even stronger inducers of NEP than the wild
type virus (Figure 5). NP and M1 expression levels are
mostly equal between the different viruses with the excep-
tion of (A149V), (L146A) and (F138A, L141A) viruses
showing slightly reduced M1 levels. All the observed dif-
ferences are modest however, and despite critical roles for
these proteins during infection, unlikely to cause any de-
fects in replication. To confirm this conclusion we used
immunofluorescence analysis to visualize NP localization
during infection with all our mutant viruses (Additional
file 1: Figure S1 and Additional file 2: Figure S2). Since
NEP and M1 are involved in the nuclear export of viral ri-
bonucleoproteins [24,32], any major flaw in their function
would show as nuclear retention of NP. All the viruses
display equal cytoplasmic localization of NP (Additional
file 1: Figure S1 and Additional file 2: Figure S2), so we
can conclude that the observed growth deficiencies are
not due to any defects in viral mRNA splicing or protein
expression.
The PI3K pathway has a dual role in influenza A virus
infection by mediating processes that are both beneficial
and detrimental for virus replication. Several studies
have shown that the PI3K pathway supports viral repli-
cation by promoting viral entry [33], inhibiting apoptosis
[34-36] and enhancing nuclear export of vRNP com-
plexes [37]. In addition, PI3K signalling is also involved
in RIG-I mediated activation of IRF3 thus contributing
to the induction of type I interferon production [38].
PI3K is activated at two points during influenza A infec-
tion, first at a very early stage stimulated by viral attach-
ment and then at a later stage of infection by NS1
binding to the p85β subunit of PI3K [33]. NS1 has also
been suggested to directly bind to Akt, a downstream
Tynell et al. Virology Journal 2014, 11:128 Page 9 of 12
http://www.virologyj.com/content/11/1/128effector of PI3K involved in diverse cellular processes in-
cluding cell differentiation, proliferation and apoptosis [39].
Diminished levels of cellular p-Akt observed in (L144A,
L146A) and (A149V) mutant virus-infected cells point
towards defects in the NS1 PI3K activating functions
(Figure 6C), which correlates with a previous observation
of the region around NES being involved in PI3K activation
[40]. Li and coworkers found the amino acid region 137–
142 to be involved in NS1-p85β interaction and showed
interference of the interaction by mutation of the amino
acids 141 and 142. In a structural study of the p85β iSH2-
NS1 -complex the Glu 142 of NS1 was speculated to be in-
volved in salt bridge formation at the complex interface
[41]. The inability of NS1 (L144A, L146A) and (A149V)
mutant viruses to activate PI3K signalling could result from
NS1 nuclear retention, but since this phenotype is not
shared by other viruses with inactivated NS1 NES signals,
it must be due to an effect independent of NS1 localization.
It is plausible that mutations close to the NS1-p85β bind-
ing site could cause structural changes big enough to dis-
rupt the salt bridge formation between NS1 Glu 142 and
p85β or just influence the interaction enough to disrupt
PI3K/Akt activation. Such disruption by itself could cause
the observed reductions in growth and IFN antagonistic
properties as evidenced by other studies where NS1-p85β
interaction has been investigated [12,41,42]. Also certain
mutations in the amino acid position 138 have been shown
to influence the NS1-p85β interaction [43,44], so it is feas-
ible that the mutations L144A, L146A and A149V might
affect it as well.
Nuclear export of proteins containing the classical
leucine-rich export signal is usually mediated by CRM1,
but with influenza A virus NS1 this is likely not the case. It
was shown previously by transfection experiments that
NS1 does not interact with CRM1 [20] and here we show
that the CRM1 inhibitor LMB fails to prevent or at least
partially impair NS1 export during the infection (Figure 8).
Examples of proteins showing nuclear export independent
of CRM1, despite harboring leucine-rich export signals, in-
clude protein kinase inhibitor (PKI) and glucocorticoid re-
ceptor, which are exported by the Ca2+-binding protein
calreticulin through a mechanism similar to CRM1-
mediated export [18,19]. It is likely that a similar alter-
native export pathway exists for NS1 as well, but this
remains to be verified by further experiments.
Conclusions
In conclusion, our data shows that the NES region of NS1
plays an extremely important role during influenza A virus
infection. It was clearly shown that the NES sequence reg-
ulates the nucleo-cytoplasmic transport of NS1. An as-
sociation with nuclear retention of NS1 and increased
phosphorylation of IRF3 was observed, but no clear correl-
ation could be established. There were obvious differencesin the growth properties of the different NES mutant vi-
ruses, and since the observed NS1 localization pattern was
a poor prognosis for the growth phenotype, it must be
concluded that the importance of NS1 NES region goes
beyond just regulating NS1 localization. Good correlation
of Akt phosphorylation with growth properties indicates
the involvement of NS1-p85β interaction, but conclusive




HEK293, A549 and MDCK cells were maintained in Eagle’s
minimum essential medium (MEM) supplemented with
0.6 μg/ml penicillin, 60 μg/ml streptomycin, 2 mM L-glu-
tamine, 20 mM HEPES and 10% fetal calf serum (FCS) at
37°C in 5% CO2. Influenza A/Udorn/72 recombinant wild-
type virus (wt) and recombinant NS1 NES -mutant viruses
were propagated in 11-day-old embryonated chicken eggs
at 34°C for 3 days.
Generation of recombinant viruses
The wild-type A/Udorn/72 virus and the recombinant
NS1 NES-mutant viruses were generated using plasmid-
based reverse genetics essentially as previously described
[45]. pHH21 plasmids containing the full-length cDNAs
for the eight A/Udorn/72 genomic RNA segments and
pcDNA plasmids coding for the A/Udorn/72 proteins
PB1, PB2, PA and NP were kindly provided by Dr. Robert
A. Lamb. NES-mutations (L141A), (L146A), (A149V),
(F138A, L141A) and (L144A, L146A) were introduced
into the pHH21-NS plasmid using specific oligonucleotide
primers and a QuikChange II Site-Directed Mutagenesis
Kit (Stratagene, La Jolla, CA). ORF NS2 was not affected
by any of the mutations. For the generation of recombin-
ant viruses a co-culture of HEK293 and MDCK cells was
co-transfected with 1 μg of each of the 12 plasmids coding
for the viral RNA segments and expression contructs
using TransIT-LT1 transfection reagent (Mirus, Madison,
WI). The transfected cells were maintained in serum-free
MEM and at 24 h post-transfection 2,5 μg/ml TPCK-
trypsin was added into the culture medium. At 3 days
post-transfection culture supernatants were harvested and
viruses were propagated through two passages followed by
plaque purification on MDCK cells. Individual plaques
were then amplified in 11-day-old embryonated chicken
eggs. NS genes of the recombinant viruses were sequenced
to verify that the generated mutations were as expected.
Antibodies
Guinea pig anti-NS1 [15] and rabbit anti-NP antibodies
[46] have been previously described. Rhodamine Red X-
labeled anti-guinea pig immunoglobulins and FITC-labeled
anti-rabbit immunoglobulins were used as secondary
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ImmunoResearch Laboratories, Inc., West Grove, PA,
USA). In Western blotting guinea pig anti-NS1 [15], rabbit
anti-Actin (sc-10731; 1:500 dilution; Santa Cruz Biotech-
nology, Santa Cruz, CA), rabbit anti-MxA [47], rabbit anti-
p-IRF3 (#4947; 1:1000 dilution: Cell Signaling Technology,
Inc., Beverly, MA, USA) and rabbit anti-p-Akt (#9271 s;
1:1000 dilution: Cell Signaling Technology,) immunoglob-
ulins were used. For anti-M1 and anti-NEP antibodies,
Glutathione S-transferase (GST) –tagged A/Udorn/72
GST-M1 and polyhistidine-tagged A/Udorn/72 His-
NEP (aa 11–121) were expressed in Escherichia coli,
purified with Glutathione-Sepharose (Amersham Biosci-
ences, Buckinghamshire, United Kingdom) or preparative
SDS-PAGE, respectively, and used to immunize rabbits
four times at 3-week intervals (100 μg or 60 μg of antigen/
immunization, respectively). As secondary antibodies
in Western blot HRP-conjugated rabbit anti-guinea pig
(1:1000 dilution; Dako, Glostrup, Denmark) and goat
anti-rabbit (1:2000 dilution; Dako) immunoglobulins
were used.
Immunofluorescence analysis
A549 cells grown on glass coverslips were infected with
the wt or NES-mutant viruses at a multiplicity of infec-
tion (MOI) -value of 1 and incubated at 37°C 5% CO2
for 1 h, after which the virus inoculum was removed and
replaced with MEM containing 2% FCS. Incubation was
resumed and at 8 h, 12 h, 16 h, 20 h and 24 h post-
infection infected cells were fixed with 3% paraformalde-
hyde at room temperature for 20 min, permeabilized
with 0,1% Triton X-100 for 5 min and processed for im-
munofluorescence microscopy as described previously
[48]. The localization of NS1 and NP in the cells were
visualized with anti-NS1 and anti-NP antibodies (1:100
dilution) and photographed on a Leica TCS NT confocal
microscope. For the leptomycin B (LMB) experiment
2 ng/ml of LMB was added on A549 cells infected with
wt virus at 3 h post-infection and the cells were fixed at
20 h post-infection and processed as described above.
Viral growth kinetics
Confluent monolayers of MDCK cells were inoculated with
the wt or NES-mutant viruses at MOI values of 0.001 and
incubated at 37°C 5% CO2. At 1 h post-infection the virus
suspensions were removed and replaced with serum-free
MEM containing 2,5 μg/ml TPCK-trypsin. Incubation was
resumed and cell culture supernatant samples were col-
lected at 12 h intervals until 48 h post-infection. Virus titers
of the samples were measured by endpoint dilution assay
on MDCK cells as per standard protocol. Briefly, serial ten-
fold dilutions till 10−8 of each sample was made and used
to infect confluent MDCK-cells on 96-well plates main-
tained in serum-free MEM with 2,5 μg/ml TPCK-trypsin.Eight parallel wells for each dilution were used. After three
days of incubation at 37°C 5% CO2 the wells were
inspected for cytopathic effect by light microscope and
TCID50/ml –values were calculated using the Spearman-
Karber method.
Infection experiments
For analyzing interferon (IFN) gene expression A549 cells
on 6-well plates were infected at MOI values of 10, 2 and
1 for 1 h followed by removal of the virus inoculum and
addition of fresh medium (2 ml/well). At 20 h post-
infection cell culture supernatants were collected and
IFN-β and IFN-λ1 levels were determined by IFN-specific
EIA assays using commercial kits (PBL Interferon source)
according to the instructions of the manufacturer. Infected
cells were collected in 1 mM EDTA, 10 mM Tris–HCl
and lysed by pulling through a 25G needle ten times. Pro-
tein concentrations of the MOI 1 lysates were analysed by
the Bradford method and equal amounts of proteins at
different dilutions (10, 5, 1, 0,5 or 0,25 μg of total protein/
lane) were loaded and separated on 12% SDS-PAGE. Pro-
teins were transferred onto Immobilon P polyvinylidene
fluoride membranes, stained (1 h at RT or overnight +4°C
for p-IRF3 and p-Akt) with antibodies against NS1, Actin,
MxA, p-IRF3 and p-Akt followed by staining with HRP-
conjugated secondary antibodies for 1 h at RT. Protein
bands were visualized on HyperMax films using an ECL
plus system (GE Healthcare). Statistical significance of
the IFN-production results were calculated by comparing
samples to the corresponding wild-type virus samples
using the students t-test. For analysis of viral protein ex-
pression kinetics, A549 cells were infected at MOI 1 as de-
scribed above and cell lysates were collected at 2 h, 4 h,
6 h, 8 h, 12 h and 24 h post-infection and immunoblotted
against NS1, NP, M1, NEP and Actin as described above.
NS1 binding assay
The full length wild type A/Udorn/72 NS1 gene (V01102)
was expressed in E. coli GST (pGEX-3X; Amersham Bio-
sciences, Buckinghamshire, U. K.) expression vector. To
create point mutations to NS1 cDNA, QuikChange™ Site-
Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA)
was used. All DNA manipulations were performed accord-
ing to standard protocols or as specified by the manu-
facturer, and the newly created gene constructs were
sequenced. Influenza A virus GST-NS1 fusion proteins
were expressed in E. coli BL21 cells, and GST-fusion pro-
teins were purified in Glutathione-Sepharose as described
[15]. In vitro-translated CPSF30 protein (TNT Coupled
Reticulocyte Lysate Systems, Promega, Madison, WI, USA)
were [35S]-labeled (PRO-MIX, Amersham Biosciences) and
allowed to bind to Sepharose-immobilized GST or GST-
NS1 fusion proteins on ice for 1 h, followed by wash-
ing. GST-NS1-bound and [35S]-labeled proteins were
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treated with Amplify reagent (Amersham Biosciences,
Buckinghamshire, U. K.) as specified by the manufac-
turer and autoradiographed.
Additional files
Additional file 1: Figure S1. Intracellular localization of NP and NS1 on
A549 cells. A549 cells were infected at MOI 1 for the times indicated with
wild type, (L141A) and (L146A) recombinant viruses before fixation and
permeabilization. Cells were stained with guinea pig anti-NS1 and rabbit
anti-NP antibodies followed by Rhodamine Red X-labeled anti-guinea pig
immunoglobulins and FITC-labeled anti-rabbit immunoglobulins. Pictures
were taken with Leica TCS NT confocal microscope.
Additional file 2: Figure S2. Intracellular localization of NP and NS1 on
A549 cells. A549 cells were infected at MOI 1 for the times indicated with
(A149V), (L144A, L146A) and (F138A, L141A) recombinant viruses before
fixation and permeabilization. Cells were stained with guinea pig anti-NS1
and rabbit anti-NP antibodies followed by Rhodamine Red X-labeled
anti-guinea pig immunoglobulins and FITC-labeled anti-rabbit
immunoglobulins. Pictures were taken with Leica TCS NT confocal
microscope.
Additional file 3: Figure S3. Comparison of NS1 expression levels. A,
lysates collected from infected A549 cells (MOI 1) at 20 h post-infection were
analyzed by SDS-PAGE and Western blotting and the amounts of NS1 and
actin were visualized by immunoblotting. Shown are three dilutions for each
sample (10, 1, 0,5 or 0,25 μg total protein/lane). B, bands from the 1 μg lanes
were processed with ImageJ software (http://imagej.nih.gov/ij/) to turn pixel
intensity into optical density (OD). NS1 OD values were normalized to actin
OD values and compared to wild type virus to get a relative estimate of NS1
expression levels between the viruses. Data shown is representative of two
independent experiments.
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